Eczema Herpeticum - Urgent Management

Key Points

• Monomorphic painful vesicles or punched-out erosions spreading over eczematous skin are classic for eczema herpeticum.
• Start systemic antiviral therapy immediately when the syndrome is suspected; do not wait for PCR confirmation.
• Assess the eyes because HSV keratitis can threaten vision.
• IV acyclovir is used for extensive, systemic, or otherwise severe disease.
• Bacterial superinfection can coexist but does not replace the need for antiviral treatment.
• Failure to improve should trigger reassessment for complications, alternative diagnosis, or antiviral resistance in high-risk patients.

Algorithm

1. Recognize monomorphic painful erosions or vesicles on a background of atopic dermatitis.
2. Assess vital signs, hydration, immune status, disease extent, and eye or neurologic symptoms.
3. Obtain HSV PCR from a lesion but start antiviral therapy immediately.
4. Use oral therapy for carefully selected stable limited disease and IV acyclovir for severe disease.
5. Consult ophthalmology urgently when ocular involvement is possible.
6. Add antibiotics only when bacterial superinfection is clinically suspected.
7. Arrange dermatology follow-up and optimize control of the underlying barrier disease.

Clinical Synopsis & Reasoning

Eczema herpeticum, also called Kaposi varicelliform eruption, is widespread herpes simplex infection occurring through a disrupted skin barrier, most commonly in atopic dermatitis. The eruption is characterized by clusters of monomorphic painful vesicles, punched-out erosions, or crusted lesions that spread beyond the distribution expected for ordinary eczema. Fever, malaise, lymphadenopathy, and substantial skin pain support the diagnosis. Lesions are often more uniform than bacterial impetigo and may involve the face, neck, or upper trunk.

Delay in antiviral therapy increases risk. Ocular involvement can cause keratoconjunctivitis, and severe infection can rarely lead to encephalitis or other systemic disease. Examine for eye pain, photophobia, red eye, visual change, or periocular lesions. Secondary bacterial infection, particularly with Staphylococcus aureus or streptococci, can coexist but should not distract from antiviral treatment.

PCR or nucleic-acid testing from a fresh vesicle or erosion confirms HSV, but treatment should start based on a convincing clinical presentation. Differential diagnoses include impetigo, varicella, zoster, hand-foot-mouth disease, contact dermatitis, and an acute flare of atopic dermatitis. The combination of systemic symptoms, pain, and monomorphic punched-out lesions is especially useful at the bedside.

Treatment Strategy & Disposition

Begin systemic antiviral therapy promptly. Stable patients with limited disease who can take oral medication may be treated with oral acyclovir or valacyclovir and very close follow-up. Admit patients with extensive involvement, systemic illness, dehydration, young age, immunocompromise, inability to tolerate oral therapy, concern for bacterial sepsis, or ocular or neurologic complications. IV acyclovir is appropriate for severe disease.

Obtain ophthalmology consultation urgently for ocular symptoms, periocular lesions with concern for eye involvement, or abnormal eye examination. Add antibacterial therapy when clinical findings suggest impetiginization, cellulitis, or bacterial sepsis; do not give antibiotics automatically in the absence of evidence for bacterial infection. Provide pain control, hydration, gentle wound care, and continuation or adjustment of underlying eczema therapy with dermatology guidance.

Use contact precautions as appropriate for uncovered HSV lesions in health care settings and reinforce careful hand hygiene. Monitor renal function during high-dose IV acyclovir and ensure adequate hydration because crystal nephropathy can occur. Improvement in fever and new lesion formation should be evident after appropriate therapy; lack of response warrants reassessment of diagnosis, resistance in immunocompromised patients, and complications.

Epidemiology / Risk Factors

• Eczema herpeticum occurs most often in patients with atopic dermatitis but can complicate other barrier disorders.
• Children and young adults are commonly affected, though disease can occur at any age.
• Poorly controlled or extensive atopic dermatitis increases susceptibility.
• Recurrence is possible after a prior episode.

Investigations

Disposition

Pharmacology

Prognosis / Complications

• Most patients improve rapidly when systemic antiviral therapy is started promptly.
• Delayed treatment increases risk for hospitalization and serious complications.
• Ocular HSV can produce corneal scarring and visual impairment.
• Recurrent HSV and chronic eczema require coordinated outpatient management.

Patient Education / Counseling

• Explain that this is a herpes infection spreading through damaged skin and requires systemic antiviral medicine.
• Avoid direct contact with active herpes lesions in others and avoid sharing items contaminated with lesion fluid.
• Seek urgent reassessment for eye pain, visual change, confusion, worsening fever, or rapidly spreading lesions.
• Maintain gentle eczema skin care after the infection improves to reduce barrier disruption.

Notes

Eczema herpeticum is one of the most important infectious complications of atopic dermatitis because it can resemble an ordinary flare early. Pain, monomorphic lesions, punched-out erosions, and fever should immediately change the management pathway.

A positive bacterial culture does not exclude HSV. Mixed infection occurs, so persistent concern for eczema herpeticum should be treated with antivirals even when impetigo is also present.

The background atopic dermatitis should be addressed after antiviral therapy is established because uncontrolled barrier inflammation can prolong discomfort and predispose to future skin infection. Gentle emollients can usually continue, while complex immunomodulator decisions should be coordinated with dermatology. In hospitalized children, fluid intake and pain deserve deliberate attention because painful facial or oral-adjacent lesions can reduce drinking well before laboratory dehydration is obvious. A patient whose lesions continue to multiply after several days of correctly dosed acyclovir should be reassessed for adherence, absorption, renal dose error, HSV resistance in an immunocompromised host, bacterial superinfection, or an alternative vesiculobullous diagnosis.

References

1. American Academy of Dermatology: Atopic Dermatitis Resources — Link
2. CDC: Herpes Simplex Virus Resources — Link